You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cervical Lymph Node Metastases

Incidence and Implications of Extracapsular Carcinoma

Jonas T. Johnson, MD; Eugene N. Myers, MD; Carlos D. Bedetti, MD; E. Leon Barnes, MD; Victor L. Schramm, Jr, MD; Patricia B. Thearle, RN

Arch Otolaryngol. 1985;111(8):534-537.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

• The incidence and prognostic significance of extracapsular spread (ECS) of tumor in cervical lymphatics was investigated. The surgical specimens from 349 patients treated for squamous cell carcinoma by radical neck dissection between 1978 and 1982 have been examined retrospectively. Follow-up data were available relative to recurrence rate, site of recurrence, and disease-free intervals. Fifty-nine percent of the patients with N1 cervical metastases had ECS. Patients were classified according to the histopathologic findings in the radical neck dissection specimens. The three groups identified were patients with normal nodes, patients with no ECS, and patients with ECS. The histopathologic evidence of ECS was associated with a statistically significant reduction in survival when compared with patients without ECS. The disease-free interval between treatment and the development of recurrent disease was shorter for patients with ECS than for patients with no ECS.

(Arch Otolaryngol 1985;111:534-537)

Prognosis following treatment of squamous cell carcinoma of . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Otolaryngology (Drs Johnson, Myers, and Schramm and Ms Thearle) and Pathology (Drs Bedetti and Barnes), University of Pittsburgh School of Medicine, Eye and Ear Hospital of Pittsburgh.


Footnotes

Accepted for publication Jan 30, 1985.

Read before the International Conference on Head and Neck Cancer, Baltimore, July 26, 1984.

Reprint requests to Department of Otolaryngology, University of Pittsburgh School of Medicine, Eye and Ear Hospital of Pittsburgh, 230 Lothrop St, Pittsburgh, PA 15213 (Dr Johnson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.